Day2 Diabetes Track Session II eapmmilan2018
27th November – 10:00 – 11:15 – Session II
T1D complications – Blindness and Kidney Disease in Europe
People with T1D must have access to groundbreaking innovations to benefit from them. JDRF encourages health-plan policies to cover prescribed T1D therapies at affordable costs and advocates for national policies that protect those with chronic diseases. Work to improve healthcare access for the T1D community has three main areas of focus – coverage, affordability and choice.
European project manager jDRF
What can Europe learn from retinopathy studies in US?
Director, Diabetes Center and Clinical Research Center, Massachusetts General Hospital, Boston, US
Large scale retinopathy screening – Large scale analysis
Chair of Pharmacogenomics, University of Dundee, Dundee, UK
Precision Medicine for Diabetic Kidney Disease across Disciplines and Continents
Professor of Internal Medicine/Nephrology and Computational Medicine and Bioinformatics, Medical School, University of Michigan, Ann Arbor, US